Anil Panmand

Title: Anil Panmand: Innovator in Pharmaceutical Chemistry

Introduction

Anil Panmand is a notable inventor based in Maharashtra, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target specific receptors associated with various diseases.

Latest Patents

Anil Panmand holds a patent for "1-Substituted 1,2,3,4-tetrahydro-1,7-naphthyridin-8-amine derivatives and their use as EP4 receptor antagonists." This invention provides a compound represented by the formula (I), wherein each symbol is defined in the specification. The compound exhibits EP4 receptor antagonistic action and is useful in the prophylaxis or treatment of EP4 receptor-associated diseases, including rheumatoid arthritis, aortic aneurysms, endometriosis, ankylosing spondylitis, and inflammatory breast cancer.

Career Highlights

Anil Panmand is currently associated with Takeda Pharmaceutical Company Limited, where he continues to innovate and contribute to the development of new therapeutic agents. His work focuses on creating effective treatments for complex medical conditions.

Collaborations

Throughout his career, Anil has collaborated with esteemed colleagues, including Bheemashankar Kulkarni and Anil M Deshpande. These collaborations have further enhanced his research and development efforts in the pharmaceutical industry.

Conclusion

Anil Panmand's contributions to pharmaceutical chemistry and his innovative patent demonstrate his commitment to advancing medical science. His work has the potential to significantly impact the treatment of various diseases, showcasing the importance of innovation in healthcare.